These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 15852732

  • 1. Adjuvant chemotherapy in resected non-small cell lung cancer.
    Cangiano R.
    Rays; 2004; 29(4):435-7. PubMed ID: 15852732
    [Abstract] [Full Text] [Related]

  • 2. Adjuvant chemotherapy for non-small cell lung cancer: contribution of the International Adjuvant Lung Trial.
    Dunant A, Pignon JP, Le Chevalier T.
    Clin Cancer Res; 2005 Jul 01; 11(13 Pt 2):5017s-5021s. PubMed ID: 16000606
    [Abstract] [Full Text] [Related]

  • 3. Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial.
    Waller D, Peake MD, Stephens RJ, Gower NH, Milroy R, Parmar MK, Rudd RM, Spiro SG.
    Eur J Cardiothorac Surg; 2004 Jul 01; 26(1):173-82. PubMed ID: 15200998
    [Abstract] [Full Text] [Related]

  • 4. Postoperative adjuvant chemotherapy for stage I non-small cell lung cancer.
    Park JH, Lee CT, Lee HW, Baek HJ, Zo JI, Shim YM.
    Eur J Cardiothorac Surg; 2005 Jun 01; 27(6):1086-91. PubMed ID: 15896623
    [Abstract] [Full Text] [Related]

  • 5. Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancer. An analysis of National Cancer Institute of Canada and intergroup trial JBR.10 and a review of the literature.
    Alam N, Shepherd FA, Winton T, Graham B, Johnson D, Livingston R, Rigas J, Whitehead M, Ding K, Seymour L.
    Lung Cancer; 2005 Mar 01; 47(3):385-94. PubMed ID: 15713522
    [Abstract] [Full Text] [Related]

  • 6. [A pilot study of induction chemotherapy with cisplatin, mitomycin C and vindesine for stage III N2 non-small cell lung cancer].
    Nishiwaki Y, Nagai K, Kodama T, Nishiyama H, Hojo H, Matsumoto T.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec 01; 31 Suppl():203-11. PubMed ID: 8007467
    [Abstract] [Full Text] [Related]

  • 7. Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer: the International Adjuvant Lung Cancer Trial Biologic Program.
    Filipits M, Pirker R, Dunant A, Lantuejoul S, Schmid K, Huynh A, Haddad V, André F, Stahel R, Pignon JP, Soria JC, Popper HH, Le Chevalier T, Brambilla E.
    J Clin Oncol; 2007 Jul 01; 25(19):2735-40. PubMed ID: 17602078
    [Abstract] [Full Text] [Related]

  • 8. The current status of adjuvant chemotherapy for resected non-small cell lung cancer.
    Socinski MA.
    Semin Oncol; 1999 Oct 01; 26(5 Suppl 15):27-33. PubMed ID: 10566608
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Optimal adjuvant therapy for non-small cell lung cancer--how to handle stage I disease.
    Wakelee H, Dubey S, Gandara D.
    Oncologist; 2007 Mar 01; 12(3):331-7. PubMed ID: 17405898
    [Abstract] [Full Text] [Related]

  • 11. Pooled analysis of the effect of age on adjuvant cisplatin-based chemotherapy for completely resected non-small-cell lung cancer.
    Früh M, Rolland E, Pignon JP, Seymour L, Ding K, Tribodet H, Winton T, Le Chevalier T, Scagliotti GV, Douillard JY, Spiro S, Shepherd FA.
    J Clin Oncol; 2008 Jul 20; 26(21):3573-81. PubMed ID: 18640938
    [Abstract] [Full Text] [Related]

  • 12. Adjuvant chemotherapy for non-small cell lung cancer: a New Zealand perspective.
    Sasidharan R, Gibbs D, Sullivan R, Simpson A, Perez D, Christmas T, McKeage M.
    N Z Med J; 2006 Nov 17; 119(1245):U2310. PubMed ID: 17146485
    [Abstract] [Full Text] [Related]

  • 13. Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial.
    Douillard JY, Rosell R, De Lena M, Riggi M, Hurteloup P, Mahe MA, Adjuvant Navelbine International Trialist Association.
    Int J Radiat Oncol Biol Phys; 2008 Nov 01; 72(3):695-701. PubMed ID: 18439766
    [Abstract] [Full Text] [Related]

  • 14. The ALPI Trial: the Italian/European experience with adjuvant chemotherapy in resectable non-small lung cancer.
    Scagliotti GV.
    Clin Cancer Res; 2005 Jul 01; 11(13 Pt 2):5011s-5016s. PubMed ID: 16000605
    [Abstract] [Full Text] [Related]

  • 15. Adjuvant chemotherapy for completely resected stage III non-small-cell lung cancer. Results of a randomized prospective study. The Japan Clinical Oncology Group.
    Ohta M, Tsuchiya R, Shimoyama M, Sawamura K, Mori T, Miyazawa N, Suemasu K, Watanabe Y, Tomita M, Terashima M.
    J Thorac Cardiovasc Surg; 1993 Oct 01; 106(4):703-8. PubMed ID: 8412266
    [Abstract] [Full Text] [Related]

  • 16. [Current status of the neo-adjuvant and adjuvant therapy for the resectable non-small cell lung cancer].
    Yamaguchi M, Fukuyama Y, Ichinose Y.
    Gan To Kagaku Ryoho; 2003 Feb 01; 30(2):203-8. PubMed ID: 12610867
    [Abstract] [Full Text] [Related]

  • 17. A meta-analysis of randomized controlled trials comparing carboplatin-based to cisplatin-based chemotherapy in advanced non-small cell lung cancer.
    Jiang J, Liang X, Zhou X, Huang R, Chu Z.
    Lung Cancer; 2007 Sep 01; 57(3):348-58. PubMed ID: 17485133
    [Abstract] [Full Text] [Related]

  • 18. [Radio-chemotherapy combination in locally advanced, inoperable, non-small cell bronchial cancers].
    Mornex F.
    Rev Pneumol Clin; 2002 Nov 01; 58(5 Pt 2):3S37-41. PubMed ID: 12538934
    [No Abstract] [Full Text] [Related]

  • 19. Class III beta-tubulin expression and benefit from adjuvant cisplatin/vinorelbine chemotherapy in operable non-small cell lung cancer: analysis of NCIC JBR.10.
    Sève P, Lai R, Ding K, Winton T, Butts C, Mackey J, Dumontet C, Dabbagh L, Aviel-Ronen S, Seymour L, Whitehead M, Tsao MS, Shepherd FA, Reiman T.
    Clin Cancer Res; 2007 Feb 01; 13(3):994-9. PubMed ID: 17289895
    [Abstract] [Full Text] [Related]

  • 20. Advances in our understanding of postoperative adjuvant chemotherapy in resectable non-small-cell lung cancer.
    Hotta K, Matsuo K, Kiura K, Ueoka H, Tanimoto M.
    Curr Opin Oncol; 2006 Mar 01; 18(2):144-50. PubMed ID: 16462183
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.